Weight loss drug reduced risk of COVID deaths in new study

New extensive study: Ozempic also beneficial for Alzheimer's and even cancer

Wegovy reduced COVID deaths in obese patients, study shows - West Hawaii Today

Novo Nordisk A/S’s Wegovy reduced deaths and illness from COVID in a large study that took place during the pandemic, more evidence of the blockbuster shot’s benefits beyond weight loss.

Wegovy and Ozempic found to have 'far-reaching benefits' and could 'slow down ageing' says new study

Participants who took semaglutide died at a lower rate from all causes, as well as from cardiovascular causes and Covid-19, researchers found

Ozempic weight loss: Jabs could slow ageing, researchers say

New studies suggest the weight loss drug could be used to treat a range of issues, including heart failure.

Ozempic: Weight-loss drug could slow down ageing and offer benefits 'far beyond' previously thought

Diabetes drug Ozempic could slow down ageing and offer "far-reaching benefits" beyond what was imagined, researchers have suggested.

Ozempic could slow down ageing, researchers suggest

Multiple studies have found the anti-obesity drug ‘has far-reaching benefits beyond what we initially imagined’.